California Nanotechnologies is trading 6.6% down at $0.22 following the release of its Q1 2027 results, which showed strong revenue growth alongside continued losses.

  • The company reported quarterly revenue of US$917,854 and an adjusted EBITDA loss of US$129,031 for the period.
  • Shares are facing additional pressure from a broader risk-off tone in the small-cap materials sector, despite the company flagging no negative surprises in its financial release.